Cargando…
Antibiotic treatment failure in children aged 1 to 59 months with World Health Organization-defined severe pneumonia in Malawi: A CPAP IMPACT trial secondary analysis
BACKGROUND: Pneumonia is a leading cause of mortality in children <5 years globally. Early identification of hospitalized children with pneumonia who may fail antibiotics could improve outcomes. We conducted a secondary analysis from the Malawi CPAP IMPACT trial evaluating risk factors for antibi...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750006/ https://www.ncbi.nlm.nih.gov/pubmed/36516197 http://dx.doi.org/10.1371/journal.pone.0278938 |
_version_ | 1784850154467098624 |
---|---|
author | Mvalo, Tisungane Smith, Andrew G. Eckerle, Michelle Hosseinipour, Mina C. Kondowe, Davie Vaidya, Dhananjay Liu, Yisi Corbett, Kelly Nansongole, Dan Mtimaukanena, Takondwa A. Lufesi, Norman McCollum, Eric D. |
author_facet | Mvalo, Tisungane Smith, Andrew G. Eckerle, Michelle Hosseinipour, Mina C. Kondowe, Davie Vaidya, Dhananjay Liu, Yisi Corbett, Kelly Nansongole, Dan Mtimaukanena, Takondwa A. Lufesi, Norman McCollum, Eric D. |
author_sort | Mvalo, Tisungane |
collection | PubMed |
description | BACKGROUND: Pneumonia is a leading cause of mortality in children <5 years globally. Early identification of hospitalized children with pneumonia who may fail antibiotics could improve outcomes. We conducted a secondary analysis from the Malawi CPAP IMPACT trial evaluating risk factors for antibiotic failure among children hospitalized with pneumonia. METHODS: Participants were 1–59 months old with World Health Organization-defined severe pneumonia and hypoxemia, severe malnutrition, and/or HIV exposure/infection. All participants received intravenous antibiotics per standard care. First-line antibiotics were benzylpenicillin and gentamicin for five days. Study staff assessed patients for first-line antibiotic failure daily between days 3–6. When identified, patients failing antibiotics were switched to second-line ceftriaxone. Analyses excluded children receiving ceftriaxone and/or deceased by hospital day two. We compared characteristics between patients with and without treatment failure and fit multivariable logistic regression models to evaluate associations between treatment failure and admission characteristics. RESULTS: From June 2015–March 2018, 644 children were enrolled and 538 analyzed. Antibiotic failure was identified in 251 (46.7%) participants, and 19/251 (7.6%) died. Treatment failure occurred more frequently with severe malnutrition (50.2% (126/251) vs 28.2% (81/287), p<0.001) and amongst those dwelling ≥10km from a health facility (22.3% (56/251) vs 15.3% (44/287), p = 0.026). Severe malnutrition occurred more frequently among children living ≥10km from a health facility than those living <10km (49.0% (49/100) vs 35.7% (275/428), p = 0.014). Children with severe malnutrition (adjusted odds ratio (aOR) 2.2 (95% CI 1.52, 3.24), p<0.001) and pre-hospital antibiotics ((aOR 1.47, 95% CI 1.01, 2.14), p = 0.043) had an elevated aOR for antibiotic treatment failure. CONCLUSION: Severe malnutrition and pre-hospital antibiotic use predicted antibiotic treatment failure in this high-risk severe pneumonia pediatric population in Malawi. Our findings suggest addressing complex sociomedical conditions like severe malnutrition and improving pneumonia etiology diagnostics will be key for better targeting interventions to improve childhood pneumonia outcomes. |
format | Online Article Text |
id | pubmed-9750006 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-97500062022-12-15 Antibiotic treatment failure in children aged 1 to 59 months with World Health Organization-defined severe pneumonia in Malawi: A CPAP IMPACT trial secondary analysis Mvalo, Tisungane Smith, Andrew G. Eckerle, Michelle Hosseinipour, Mina C. Kondowe, Davie Vaidya, Dhananjay Liu, Yisi Corbett, Kelly Nansongole, Dan Mtimaukanena, Takondwa A. Lufesi, Norman McCollum, Eric D. PLoS One Research Article BACKGROUND: Pneumonia is a leading cause of mortality in children <5 years globally. Early identification of hospitalized children with pneumonia who may fail antibiotics could improve outcomes. We conducted a secondary analysis from the Malawi CPAP IMPACT trial evaluating risk factors for antibiotic failure among children hospitalized with pneumonia. METHODS: Participants were 1–59 months old with World Health Organization-defined severe pneumonia and hypoxemia, severe malnutrition, and/or HIV exposure/infection. All participants received intravenous antibiotics per standard care. First-line antibiotics were benzylpenicillin and gentamicin for five days. Study staff assessed patients for first-line antibiotic failure daily between days 3–6. When identified, patients failing antibiotics were switched to second-line ceftriaxone. Analyses excluded children receiving ceftriaxone and/or deceased by hospital day two. We compared characteristics between patients with and without treatment failure and fit multivariable logistic regression models to evaluate associations between treatment failure and admission characteristics. RESULTS: From June 2015–March 2018, 644 children were enrolled and 538 analyzed. Antibiotic failure was identified in 251 (46.7%) participants, and 19/251 (7.6%) died. Treatment failure occurred more frequently with severe malnutrition (50.2% (126/251) vs 28.2% (81/287), p<0.001) and amongst those dwelling ≥10km from a health facility (22.3% (56/251) vs 15.3% (44/287), p = 0.026). Severe malnutrition occurred more frequently among children living ≥10km from a health facility than those living <10km (49.0% (49/100) vs 35.7% (275/428), p = 0.014). Children with severe malnutrition (adjusted odds ratio (aOR) 2.2 (95% CI 1.52, 3.24), p<0.001) and pre-hospital antibiotics ((aOR 1.47, 95% CI 1.01, 2.14), p = 0.043) had an elevated aOR for antibiotic treatment failure. CONCLUSION: Severe malnutrition and pre-hospital antibiotic use predicted antibiotic treatment failure in this high-risk severe pneumonia pediatric population in Malawi. Our findings suggest addressing complex sociomedical conditions like severe malnutrition and improving pneumonia etiology diagnostics will be key for better targeting interventions to improve childhood pneumonia outcomes. Public Library of Science 2022-12-14 /pmc/articles/PMC9750006/ /pubmed/36516197 http://dx.doi.org/10.1371/journal.pone.0278938 Text en © 2022 Mvalo et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Mvalo, Tisungane Smith, Andrew G. Eckerle, Michelle Hosseinipour, Mina C. Kondowe, Davie Vaidya, Dhananjay Liu, Yisi Corbett, Kelly Nansongole, Dan Mtimaukanena, Takondwa A. Lufesi, Norman McCollum, Eric D. Antibiotic treatment failure in children aged 1 to 59 months with World Health Organization-defined severe pneumonia in Malawi: A CPAP IMPACT trial secondary analysis |
title | Antibiotic treatment failure in children aged 1 to 59 months with World Health Organization-defined severe pneumonia in Malawi: A CPAP IMPACT trial secondary analysis |
title_full | Antibiotic treatment failure in children aged 1 to 59 months with World Health Organization-defined severe pneumonia in Malawi: A CPAP IMPACT trial secondary analysis |
title_fullStr | Antibiotic treatment failure in children aged 1 to 59 months with World Health Organization-defined severe pneumonia in Malawi: A CPAP IMPACT trial secondary analysis |
title_full_unstemmed | Antibiotic treatment failure in children aged 1 to 59 months with World Health Organization-defined severe pneumonia in Malawi: A CPAP IMPACT trial secondary analysis |
title_short | Antibiotic treatment failure in children aged 1 to 59 months with World Health Organization-defined severe pneumonia in Malawi: A CPAP IMPACT trial secondary analysis |
title_sort | antibiotic treatment failure in children aged 1 to 59 months with world health organization-defined severe pneumonia in malawi: a cpap impact trial secondary analysis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750006/ https://www.ncbi.nlm.nih.gov/pubmed/36516197 http://dx.doi.org/10.1371/journal.pone.0278938 |
work_keys_str_mv | AT mvalotisungane antibiotictreatmentfailureinchildrenaged1to59monthswithworldhealthorganizationdefinedseverepneumoniainmalawiacpapimpacttrialsecondaryanalysis AT smithandrewg antibiotictreatmentfailureinchildrenaged1to59monthswithworldhealthorganizationdefinedseverepneumoniainmalawiacpapimpacttrialsecondaryanalysis AT eckerlemichelle antibiotictreatmentfailureinchildrenaged1to59monthswithworldhealthorganizationdefinedseverepneumoniainmalawiacpapimpacttrialsecondaryanalysis AT hosseinipourminac antibiotictreatmentfailureinchildrenaged1to59monthswithworldhealthorganizationdefinedseverepneumoniainmalawiacpapimpacttrialsecondaryanalysis AT kondowedavie antibiotictreatmentfailureinchildrenaged1to59monthswithworldhealthorganizationdefinedseverepneumoniainmalawiacpapimpacttrialsecondaryanalysis AT vaidyadhananjay antibiotictreatmentfailureinchildrenaged1to59monthswithworldhealthorganizationdefinedseverepneumoniainmalawiacpapimpacttrialsecondaryanalysis AT liuyisi antibiotictreatmentfailureinchildrenaged1to59monthswithworldhealthorganizationdefinedseverepneumoniainmalawiacpapimpacttrialsecondaryanalysis AT corbettkelly antibiotictreatmentfailureinchildrenaged1to59monthswithworldhealthorganizationdefinedseverepneumoniainmalawiacpapimpacttrialsecondaryanalysis AT nansongoledan antibiotictreatmentfailureinchildrenaged1to59monthswithworldhealthorganizationdefinedseverepneumoniainmalawiacpapimpacttrialsecondaryanalysis AT mtimaukanenatakondwaa antibiotictreatmentfailureinchildrenaged1to59monthswithworldhealthorganizationdefinedseverepneumoniainmalawiacpapimpacttrialsecondaryanalysis AT lufesinorman antibiotictreatmentfailureinchildrenaged1to59monthswithworldhealthorganizationdefinedseverepneumoniainmalawiacpapimpacttrialsecondaryanalysis AT mccollumericd antibiotictreatmentfailureinchildrenaged1to59monthswithworldhealthorganizationdefinedseverepneumoniainmalawiacpapimpacttrialsecondaryanalysis |